Skip to main content
Fig. 5 | BMC Cancer

Fig. 5

From: SMAD4 Y353C promotes the progression of PDAC

Fig. 5

SMAD4 Y353C reduces the expression of E-cadherin but promotes that of Vimentin. a, b Western blot analysis of EMT markers was performed in the SW1990 and Panc-1 cell lines. GAPDH was included as a loading control. c The relative mRNA levels of EMT markers were examined by qRT-PCR. All statistical data were analysed by one-way ANOVA. Three independent experiments were conducted for each assay (*Pā€‰<ā€‰0.05 vs SMAD4 wt)

Back to article page